Related Experiment Video
Updated: Sep 26, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
The knockdown of the Mediator complex subunit MED15 restrains urothelial bladder cancer cells' malignancy
Isabella Syring1, Richard Weiten1, Tim Müller2
1Clinic for Urology and Paediatric Urology, University Hospital of Bonn, D-53127 Bonn, Germany.
Abstract:
The Mediator complex, a multi-subunit protein complex, plays an integral role in regulating transcription. Genetic alterations of the mediator subunit 15 (MED15) in separate tumor entities have been described previously. However, till now, not much is known about the role of MED15 in urothelial bladder cancer (BCa). Using cBioPortal, database analysis was executed for the mRNA expression and survival analysis of MED15 in BCa. Immunohistochemistry (IHC) analysis against MED15 was performed on tissue microarrays with 18 benign, 126 BCa, and 38 metastases samples. The intensity evaluation was performed using a staining intensity score from 0 to 3 and associated with clinicopathological data. The BCa cell lines T24 and TCCSUP were used for the functional investigation. After the MED15 knockdown by small interfering (si)RNA, cell proliferation, migration and invasion were investigated. On the mRNA level, only a low number of alterations (2%) was found for MED15 in BCa. Due to the small count of events, there were no significant differences or tendencies in survival. For IHC, MED15 was found to have a higher expression in non-muscle invasive BCa compared with benign and muscle invasive BCa. For survival analysis, no significant differences between samples with or without overexpression of MED15 were found. In the functional analysis, proliferation, migration, and invasion were significantly reduced in BCa-cells following the transient siRNA-mediated MED15 knockdown. In summary, MED15 appears to play a role in the tumor parameters proliferation, migration, and invasion in BCa, but further investigations are necessary.
Insights
Mediator subunit 15 (MED15) plays a role in urothelial bladder cancer (BCa) progression. While genetic alterations are rare, MED15 influences cell proliferation, migration, and invasion in BCa.
Area of Science:
- Molecular Biology
- Cancer Research
- Urothelial Carcinogenesis
Background:
- The Mediator complex is crucial for gene transcription regulation.
- Genetic alterations in MED15 have been noted in other cancers, but its role in urothelial bladder cancer (BCa) remains unclear.
Purpose of the Study:
- To investigate the role of MED15 in urothelial bladder cancer (BCa).
- To analyze MED15 mRNA expression, protein levels, and its functional impact on BCa cell behavior.
Main Methods:
- Database analysis of MED15 mRNA expression and survival in BCa using cBioPortal.
- Immunohistochemistry (IHC) of MED15 on benign, BCa, and metastasis tissue microarrays.
- Functional studies involving MED15 knockdown via siRNA in BCa cell lines (T24, TCCSUP) to assess proliferation, migration, and invasion.
Main Results:
- Low frequency (2%) of MED15 genetic alterations observed in BCa mRNA data; no significant survival impact.
- MED15 protein expression was higher in non-muscle invasive BCa compared to benign and muscle invasive BCa.
- MED15 knockdown significantly reduced proliferation, migration, and invasion in BCa cell lines.
Conclusions:
- MED15 expression is altered in BCa, particularly in non-muscle invasive stages.
- MED15 knockdown demonstrates its functional importance in reducing key BCa tumor parameters.
- Further research is warranted to fully elucidate MED15's role in BCa pathogenesis and its therapeutic potential.
Related Concept Videos
Abnormal Proliferation
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...

